• Contact Us
  • About Us
Saturday, August 26, 2023
  • Login
MetroBusinessNews
  • Home
  • Economy
  • Politics
  • News
  • Companies and Markets
  • Energy
  • Sports
  • Real Estate
No Result
View All Result
  • Home
  • Economy
  • Politics
  • News
  • Companies and Markets
  • Energy
  • Sports
  • Real Estate
No Result
View All Result
MetroBusinessNews
No Result
View All Result
ADVERTISEMENT
Home News

French firm takes over Nigerian drug manufacturing company, Swipha

metro by metro
March 24, 2017
in News
0
0
SHARES
0
VIEWS

Biogaran, a French pharmaceutical company specialised in generic and biosimilar medicines, and a subsidiary of Servier, on Fridayannounced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality.

This is an important step forward in the internationalisation of the French company Biogaran.
In order to develop new markets to meet its commitment to provide all patients with quality medication, Biogaran, a pioneer in generics and biosimilars, and a subsidiary of Servier, has just taken over Swipha, a Nigerian pharmaceutical company that produces medicines to meet local health needs. Its portfolio is mainly focused on three families of products: anti-anxiety and tranquillizers, antimalarial drugs and antibiotics, which treat Nigeria’s most widespread infections and health issues.
Swipha was the first Nigerian pharmaceutical company to obtain ISO 9001 certification in 2007. Approved by the World Health Organization (WHO) in 2014, Swipha employs 300 people locally and generated record sales of NGN 4bn (approximately € 20 million) in 2012. Beyond its production unit, the company also has a wide distribution network covering most parts of Nigeria, Africa’s most dynamic country, with more than 184 million inhabitants in 2016 according to the IMF.
Health issues are particularly important in Africa. Beyond significant needs for good quality, affordable and efficient medicines, the problem of counterfeits is also becoming of concern. The WHO estimates that 100,000 deaths are due to fake medicines in Africa every year. In this context, supplying Nigeria’s population with reliable medicines that are produced locally is a strong commitment made by Biogaran.
“Biogaran’s international expansion strategy is to create synergies by bringing its expertise and investment capacity in production tools to existing structures”, commented Pascal Brière, President of Biogaran. “Swipha’s know-how, network and reputation have immediately convinced us that it was the right partner for us. Likewise, Nigeria quickly came out as the best entry point on the African continent with its strong population and solid economic fundamentals, including a very dynamic market economy”.

Read Also

Emeka, Son of Phillips Oduoza, NOVA Merchant Bank Chair, Dies at 27

BRICS Invites Saudi Arabia, Ethiopia, UAE, 3 Others To Join Alliance

Canadian Finance Minister, Who Does Not Own Car, Fined For Speeding

Previous Post

World Tuberculosis Day: Nigeria outlines plans to improve identification, treatment

Next Post

World Bank approves $200 mln loan for Nigerian farmers

Related Posts

Emeka, Son of Phillips Oduoza, NOVA Merchant Bank Chair, Dies at 27
News

Emeka, Son of Phillips Oduoza, NOVA Merchant Bank Chair, Dies at 27

August 25, 2023
BRICS Invites Saudi Arabia, Ethiopia, UAE, 3 Others To Join Alliance
News

BRICS Invites Saudi Arabia, Ethiopia, UAE, 3 Others To Join Alliance

August 24, 2023
Canadian Finance Minister, Who Does Not Own Car, Fined For Speeding
News

Canadian Finance Minister, Who Does Not Own Car, Fined For Speeding

August 23, 2023
Forex Market Volatility Puts Rates Unification Policy under Scrutiny, Tinubu, summons CBN Gov
News

‘We Have A Duty To Meet Expectations of Nigerians’, Tinubu Charges New Ministers

August 21, 2023
Next Post
World Bank

World Bank approves $200 mln loan for Nigerian farmers

Abolish ‘human exploitation’ once and for all, UNESCO chief urges

August 25, 2023
Nigeria’s GDP Growth Slows To 2.51% In Q2, 2023 Amid Challenging Economic Condition

Nigeria’s GDP Growth Slows To 2.51% In Q2, 2023 Amid Challenging Economic Condition

August 25, 2023
Minister Says Port Harcourt Refinery To Be Ready In December 2023

Minister Says Port Harcourt Refinery To Be Ready In December 2023

August 25, 2023
ADVERTISEMENT
MetroBusinessNews

© 2022 Metro Business News

Navigate Site

  • Contact Us
  • About Us

Follow Us

No Result
View All Result
  • Home
  • Economy
  • Politics
  • News
  • Companies and Markets
  • Energy
  • Sports
  • Real Estate

© 2022 Metro Business News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Go to mobile version